Paul Tudor Jones Merck & Co., Inc. Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 1,141,800 shares of MRK stock, worth $98.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,141,800

Previous 774,203 47.48%

Holding current value

$98.2 Million

Previous $69.5 Million 30.06%

% of portfolio

0.21%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$83.01 - $101.02 $60 Million - $73.1 Million	723,375 Added 1423.18%	774,203 $69.5 Million
Q4 2024 Feb 14, 2025	SELL	$96.31 - $114.76 $11.3 Million - $13.5 Million	-117,676 Reduced 69.84%	50,828 $5.06 Million
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $13.9 Million - $16.1 Million	125,129 Added 288.48%	168,504 $19.1 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $5.37 Million - $5.77 Million	43,375 New	43,375 $5.37 Million
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $8.73 Million - $9.69 Million	84,792 New	84,792 $8.73 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $4.05 Million - $4.52 Million	39,331 New	39,331 $4.18 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $781,310 - $877,715	9,243 New	9,243 $796,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $2.87 Million - $3.22 Million	-39,080 Reduced 89.43%	4,619 $379,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $2.04 Million - $2.55 Million	28,155 Added 181.13%	43,699 $3.35 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1.09 Million - $1.21 Million	15,544 New	15,544 $1.21 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $1.8 Million - $2.12 Million	-26,127 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.02 Million - $1.13 Million	14,154 Added 118.22%	26,127 $2.14 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $3.32 Million - $3.76 Million	-45,327 Reduced 79.1%	11,973 $993,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $2.1 Million - $2.39 Million	29,881 Added 108.98%	57,300 $4.43 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $3.7 Million - $5.12 Million	-58,330 Reduced 68.02%	27,419 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $6.65 Million - $7.51 Million	85,749 New	85,749 $7.8 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $665,319 - $725,222	-8,745 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $610,750 - $713,504	8,745 New	8,745 $733,000
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $3.25 Million - $3.82 Million	-63,992 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $2.35 Million - $2.74 Million	46,199 Added 259.65%	63,992 $3.49 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $918,474 - $1.1 Million	17,793	17,793 $1 Million

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $218B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account